Comprehensive medicinal chemistry II: 1 Global perspective
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2007
|
| Ausgabe: | 1. ed. |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXVII, 854 S. Ill., graph. Darst. |
| ISBN: | 0080445144 9780080445144 |
Internformat
MARC
| LEADER | 00000nam a2200000 cc4500 | ||
|---|---|---|---|
| 001 | BV022238824 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 070124s2007 ad|| |||| 00||| eng d | ||
| 020 | |a 0080445144 |9 0-08-044514-4 | ||
| 020 | |a 9780080445144 |9 978-0-08-044514-4 | ||
| 035 | |a (OCoLC)634912187 | ||
| 035 | |a (DE-599)BVBBV022238824 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-20 | ||
| 245 | 1 | 0 | |a Comprehensive medicinal chemistry II |n 1 |p Global perspective |c ed.-in-chief: John B. Taylor... |
| 250 | |a 1. ed. | ||
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2007 | |
| 300 | |a XXVII, 854 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 700 | 1 | |a Taylor, John B. |e Sonstige |4 oth | |
| 773 | 0 | 8 | |w (DE-604)BV022238800 |g 1 |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015449784&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015449784 | ||
Datensatz im Suchindex
| _version_ | 1804136229728419840 |
|---|---|
| adam_text | COMPREHENSIVE MEDICINAL CHEMISTRY II EDITORS-IN-CHIEF DR JOHN B TAYLOR
FORMER SENIOR VICE-PRESIDENT FOR DRUG DISCOVERY, RHONE-POULENC RARER,
WORLDWIDE, UK PROFESSOR DAVID J TRIGGLE STATE UNIVERSITY OF NEW YORK,
BUFFALO, NY, USA VOLUME 1 GLOBAL PERSPECTIVE VOLUME EDITOR DR PETER D
KENNEWELL SWINDON, UK ELSEVIER AMSTERDAM BOSTON HEIDELBERG LONDON
NKWYORK OXFORD PARIS SAN DIEGO SAN FRANCISCO SINGAPORE SYDNEY TOKYO
CONTENTS CONTENTS OF ALL VOLUMES XI PREFACE XIX PREFACE TO VOLUME 1 XXI
EDITORS-IN-CHIEF XXIII EDITOR OF VOLUME 1 XXIV CONTRIBUTORS TO VOLUME 1
XXV HISTORICAL PERSPECTIVE AND OUTLOOK 1.01 REFLECTIONS OF A MEDICINAL
CHEMIST: FORMATIVE YEARS THROUGH THIRTY-SEVEN YEARS SERVICE IN THE
PHARMACEUTICAL INDUSTRY 1 R F HIRSCHMANN, UNIVERSITY OF PENNSYLVANIA,
PHILADELPHIA, PA, USA AND J L STURCHIO, MERCK & CO., INC., WHITE HOUSE
STATION. NJ. USA 1.02 DRUG DISCOVERY: HISTORICAL PERSPECTIVE. CURRENT
STATUS, AND OUTLOOK 29 P W ERHARDT, UNIVERSITY OF TOLEDO, OH, USA AND J
R PROUDFOOT. BOCHRINGER INGELHEIM INC., RIDGEFIELD, CT, USA 1.03 MAJOR
DRUG INTRODUCTIONS 97 P D KENNEWELL, SWINDON, UK THE IMPACT OF NEW
GENOMIC TECHNOLOGIES 1 .04 EPIGENETICS 251 W W WEBER. UNIVERSITY OF
MICHIGAN, ANN ARBOR, ML, USA 1.05 PERSONALIZED MEDICINE 279 D GURWITZ,
TEL-AVIV UNIVERSITY, TEL-AVIV, ISRAEL AND V G MANOLOPOULOS. DEMOCRITUS
UNIVERSITY OF THRACE, ALEXANDROIIPOLIS, GREECE 1.06 GENE THERAPY 297 M
THANOU, IMPERIAL COLLEGE LONDON. LONDON. UK. AND S WADDINGTON.
UNIVERSITY COLLEGE LONDON, LONDON. UK, AND A D MILLER, IMPERIAL COLLEGE
LONDON, LONDON, UK VI II CONTENTS SOURCES OF NEW DRUGS 1.07 OVERVIEW OF
SOURCES OF NEW DRUGS 321 D BROWN, ALCHEMY BIOMEDICAL CONSULTING,
CAMBRIDGE, UK 1.08 NATURAL PRODUCT SOURCES OF DRUGS: PLANTS, MICROBES,
MARINE ORGANISMS, AND ANIMALS 355 G M CRAGG AND D J NEWMAN, NCI,
FREDERICK, MD, USA 1.09 TRADITIONAL MEDICINES 405 L A MITSCHER,
UNIVERSITY OF KANSAS, LAWRENCE, KS, USA 1.10 BIOLOGICAL MACROMOLECULES
431 J K OSBOURN, CAMBRIDGE ANTIBODY TECHNOLOGY, CAMBRIDGE, UK 1.11
NUTRACEUTICALS 449 P A LACHANCE AND Y T DAS, RUTGERS - THE STATE
UNIVERSITY OF NEW JERSEY, NEW BRUNSWICK, NJ, USA ANIMAL EXPERIMENTATION
1.12 ALTERNATIVES TO ANIMAL TESTING 463 R D COMBES, FRAME, NOTTINGHAM,
UK THE ROLE OF INDUSTRY 1.13 THE ROLE OF SMALL- OR MEDIUM-SIZED
ENTERPRISES IN DRUG DISCOVERY 489 C G NEWTON, BIOFOCUS DRI, SAFFRON
WALDEN, UK 1.14 THE ROLE OF THE PHARMACEUTICAL INDUSTRY 527 R BARKER,
ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (ABPIJ, LONDON, UK
AND M DARNBROUGH^ LONDON, UK 1.15 THE ROLE OF THE VENTURE CAPITALIST 553
D J BOWER, UNIVERSITY OF DUNDEE, SCOTLAND, UK 1.16 INDUSTRY-ACADEMIC
RELATIONSHIPS 571 M DARNBROUGH, LONDON, UK AND M SKINGLE,
GLAXOSMITHKLINE, STEVENAGE, UK DRUG DISCOVERY: REVOLUTION, DECLINE? 1.17
IS THE BIOTECHNOLOGY REVOLUTION A MYTH? 591 M M HOPKINS, UNIVERSITY OF
SUSSEX, BRIGHTON, UK, AND A KRAFT AND P A MARTIN, NOTTINGHAM UNIVERSITY,
NOTTINGHAM, UK, AND P NIGHTINGALE AND S MAHDI, UNIVERSITY OF SUSSEX,
BRIGHTON, UK 1.18 THE APPARENT DECLINING EFFICIENCY OF DRUG DISCOVERY
615 D TRIST, E RATTI. AND L DA ROS, GLAXOSMITHKLINE, VERONA, ITALY
HEALTHCARE IN THE SOCIAL CONTEXT 1.19 HOW MUCH IS ENOUGH OR TOO LITTLE:
ASSESSING HEALTHCARE DEMAND IN DEVELOPED COUNTRIES 627 D CALLAHAN, THE
HASTINGS CENTER, GARRISON, NY, USA 1.20 HEALTH DEMANDS IN DEVELOPING
COUNTRIES 637 A A WASUNNA, THE HASTINGS CENTER, GARRISON, NY, USA 1.21
ORPHAN DRUGS AND GENERICS 655 C-P MILNE AND L A CABANILLA, TUFTS
UNIVERSITY, BOSTON, MA, USA CONTENTS ETHICAL ISSUES 1.22 BIOETHICAL
ISSUES IN MEDICINAL CHEMISTRY AND DRUG TREATMENT 6S] P R WOLPE,
UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA. USA, AND M SAUL. MJSAHL
CONSULTING, PHILADELPHIA, PA, USA, AND J R HOWARD. UNIVERSITY OF
PENNSYLVANIA, PHILADELPHIA, PA, USA 1.23 ETHICAL ISSUES AND CHALLENGES
FACING THE PHARMACEUTICAL INDUSTRY 709 M L EATON, STANFORD UNIVERSITY,
GRADUATE SCHOOL OF BUSINESS, STANFORD, (A. I SA FUNDING AND REGULATION
OF RESEARCH 1.24 THE ROLE OF GOVERNMENT IN HEALTH RESEARCH 725 J K
OZAWA, SRI INTERNATIONAL, ARLINGTON, VA, USA AND Q C FRANCO. STRUT EDGE.
WASHINGTON. DC. USA 1.25 POSTMARKETING SURVEILLANCE 755 A LI WAN PO,
CENTRE FOR EVIDENCE-BASED PHARMACOTHERAPY, NOTTINGHAM, UK INTELLECTUAL
PROPERTY 1.26 INTELLECTUAL PROPERTY RIGHTS AND PATENTS 779 J COCK BAIN.
FRANK B DEHN & CO. OXFORD, UK SUBJECT INDEX 817
|
| adam_txt |
COMPREHENSIVE MEDICINAL CHEMISTRY II EDITORS-IN-CHIEF DR JOHN B TAYLOR
FORMER SENIOR VICE-PRESIDENT FOR DRUG DISCOVERY, RHONE-POULENC RARER,
WORLDWIDE, UK PROFESSOR DAVID J TRIGGLE STATE UNIVERSITY OF NEW YORK,
BUFFALO, NY, USA VOLUME 1 GLOBAL PERSPECTIVE VOLUME EDITOR DR PETER D
KENNEWELL SWINDON, UK ELSEVIER AMSTERDAM BOSTON HEIDELBERG LONDON
NKWYORK OXFORD PARIS SAN DIEGO SAN FRANCISCO SINGAPORE SYDNEY TOKYO
CONTENTS CONTENTS OF ALL VOLUMES XI PREFACE XIX PREFACE TO VOLUME 1 XXI
EDITORS-IN-CHIEF XXIII EDITOR OF VOLUME 1 XXIV CONTRIBUTORS TO VOLUME 1
XXV HISTORICAL PERSPECTIVE AND OUTLOOK 1.01 REFLECTIONS OF A MEDICINAL
CHEMIST: FORMATIVE YEARS THROUGH THIRTY-SEVEN YEARS SERVICE IN THE
PHARMACEUTICAL INDUSTRY 1 R F HIRSCHMANN, UNIVERSITY OF PENNSYLVANIA,
PHILADELPHIA, PA, USA AND J L STURCHIO, MERCK & CO., INC., WHITE HOUSE
STATION. NJ. USA 1.02 DRUG DISCOVERY: HISTORICAL PERSPECTIVE. CURRENT
STATUS, AND OUTLOOK 29 P W ERHARDT, UNIVERSITY OF TOLEDO, OH, USA AND J
R PROUDFOOT. BOCHRINGER INGELHEIM INC., RIDGEFIELD, CT, USA 1.03 MAJOR
DRUG INTRODUCTIONS 97 P D KENNEWELL, SWINDON, UK THE IMPACT OF NEW
GENOMIC TECHNOLOGIES 1 .04 EPIGENETICS 251 W W WEBER. UNIVERSITY OF
MICHIGAN, ANN ARBOR, ML, USA 1.05 PERSONALIZED MEDICINE 279 D GURWITZ,
TEL-AVIV UNIVERSITY, TEL-AVIV, ISRAEL AND V G MANOLOPOULOS. DEMOCRITUS
UNIVERSITY OF THRACE, ALEXANDROIIPOLIS, GREECE 1.06 GENE THERAPY 297 M
THANOU, IMPERIAL COLLEGE LONDON. LONDON. UK. AND S WADDINGTON.
UNIVERSITY COLLEGE LONDON, LONDON. UK, AND A D MILLER, IMPERIAL COLLEGE
LONDON, LONDON, UK VI II CONTENTS SOURCES OF NEW DRUGS 1.07 OVERVIEW OF
SOURCES OF NEW DRUGS 321 D BROWN, ALCHEMY BIOMEDICAL CONSULTING,
CAMBRIDGE, UK 1.08 NATURAL PRODUCT SOURCES OF DRUGS: PLANTS, MICROBES,
MARINE ORGANISMS, AND ANIMALS 355 G M CRAGG AND D J NEWMAN, NCI,
FREDERICK, MD, USA 1.09 TRADITIONAL MEDICINES 405 L A MITSCHER,
UNIVERSITY OF KANSAS, LAWRENCE, KS, USA 1.10 BIOLOGICAL MACROMOLECULES
431 J K OSBOURN, CAMBRIDGE ANTIBODY TECHNOLOGY, CAMBRIDGE, UK 1.11
NUTRACEUTICALS 449 P A LACHANCE AND Y T DAS, RUTGERS - THE STATE
UNIVERSITY OF NEW JERSEY, NEW BRUNSWICK, NJ, USA ANIMAL EXPERIMENTATION
1.12 ALTERNATIVES TO ANIMAL TESTING 463 R D COMBES, FRAME, NOTTINGHAM,
UK THE ROLE OF INDUSTRY 1.13 THE ROLE OF SMALL- OR MEDIUM-SIZED
ENTERPRISES IN DRUG DISCOVERY 489 C G NEWTON, BIOFOCUS DRI, SAFFRON
WALDEN, UK 1.14 THE ROLE OF THE PHARMACEUTICAL INDUSTRY 527 R BARKER,
ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (ABPIJ, LONDON, UK
AND M DARNBROUGH^ LONDON, UK 1.15 THE ROLE OF THE VENTURE CAPITALIST 553
D J BOWER, UNIVERSITY OF DUNDEE, SCOTLAND, UK 1.16 INDUSTRY-ACADEMIC
RELATIONSHIPS 571 M DARNBROUGH, LONDON, UK AND M SKINGLE,
GLAXOSMITHKLINE, STEVENAGE, UK DRUG DISCOVERY: REVOLUTION, DECLINE? 1.17
IS THE BIOTECHNOLOGY REVOLUTION A MYTH? 591 M M HOPKINS, UNIVERSITY OF
SUSSEX, BRIGHTON, UK, AND A KRAFT AND P A MARTIN, NOTTINGHAM UNIVERSITY,
NOTTINGHAM, UK, AND P NIGHTINGALE AND S MAHDI, UNIVERSITY OF SUSSEX,
BRIGHTON, UK 1.18 THE APPARENT DECLINING EFFICIENCY OF DRUG DISCOVERY
615 D TRIST, E RATTI. AND L DA ROS, GLAXOSMITHKLINE, VERONA, ITALY
HEALTHCARE IN THE SOCIAL CONTEXT 1.19 HOW MUCH IS ENOUGH OR TOO LITTLE:
ASSESSING HEALTHCARE DEMAND IN DEVELOPED COUNTRIES 627 D CALLAHAN, THE
HASTINGS CENTER, GARRISON, NY, USA 1.20 HEALTH DEMANDS IN DEVELOPING
COUNTRIES 637 A A WASUNNA, THE HASTINGS CENTER, GARRISON, NY, USA 1.21
ORPHAN DRUGS AND GENERICS 655 C-P MILNE AND L A CABANILLA, TUFTS
UNIVERSITY, BOSTON, MA, USA CONTENTS ETHICAL ISSUES 1.22 BIOETHICAL
ISSUES IN MEDICINAL CHEMISTRY AND DRUG TREATMENT 6S] P R WOLPE,
UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA. USA, AND M SAUL. MJSAHL
CONSULTING, PHILADELPHIA, PA, USA, AND J R HOWARD. UNIVERSITY OF
PENNSYLVANIA, PHILADELPHIA, PA, USA 1.23 ETHICAL ISSUES AND CHALLENGES
FACING THE PHARMACEUTICAL INDUSTRY 709 M L EATON, STANFORD UNIVERSITY,
GRADUATE SCHOOL OF BUSINESS, STANFORD, (A. I SA FUNDING AND REGULATION
OF RESEARCH 1.24 THE ROLE OF GOVERNMENT IN HEALTH RESEARCH 725 J K
OZAWA, SRI INTERNATIONAL, ARLINGTON, VA, USA AND Q C FRANCO. STRUT EDGE.
WASHINGTON. DC. USA 1.25 POSTMARKETING SURVEILLANCE 755 A LI WAN PO,
CENTRE FOR EVIDENCE-BASED PHARMACOTHERAPY, NOTTINGHAM, UK INTELLECTUAL
PROPERTY 1.26 INTELLECTUAL PROPERTY RIGHTS AND PATENTS 779 J COCK BAIN.
FRANK B DEHN & CO. OXFORD, UK SUBJECT INDEX 817 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV022238824 |
| ctrlnum | (OCoLC)634912187 (DE-599)BVBBV022238824 |
| edition | 1. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01119nam a2200301 cc4500</leader><controlfield tag="001">BV022238824</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070124s2007 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080445144</subfield><subfield code="9">0-08-044514-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080445144</subfield><subfield code="9">978-0-08-044514-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)634912187</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022238824</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comprehensive medicinal chemistry II</subfield><subfield code="n">1</subfield><subfield code="p">Global perspective</subfield><subfield code="c">ed.-in-chief: John B. Taylor...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVII, 854 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taylor, John B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="w">(DE-604)BV022238800</subfield><subfield code="g">1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015449784&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015449784</subfield></datafield></record></collection> |
| id | DE-604.BV022238824 |
| illustrated | Illustrated |
| index_date | 2024-07-02T16:35:11Z |
| indexdate | 2024-07-09T20:53:05Z |
| institution | BVB |
| isbn | 0080445144 9780080445144 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015449784 |
| oclc_num | 634912187 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-20 |
| physical | XXVII, 854 S. Ill., graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Elsevier |
| record_format | marc |
| spelling | Comprehensive medicinal chemistry II 1 Global perspective ed.-in-chief: John B. Taylor... 1. ed. Amsterdam [u.a.] Elsevier 2007 XXVII, 854 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Taylor, John B. Sonstige oth (DE-604)BV022238800 1 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015449784&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Comprehensive medicinal chemistry II |
| title | Comprehensive medicinal chemistry II |
| title_auth | Comprehensive medicinal chemistry II |
| title_exact_search | Comprehensive medicinal chemistry II |
| title_exact_search_txtP | Comprehensive medicinal chemistry II |
| title_full | Comprehensive medicinal chemistry II 1 Global perspective ed.-in-chief: John B. Taylor... |
| title_fullStr | Comprehensive medicinal chemistry II 1 Global perspective ed.-in-chief: John B. Taylor... |
| title_full_unstemmed | Comprehensive medicinal chemistry II 1 Global perspective ed.-in-chief: John B. Taylor... |
| title_short | Comprehensive medicinal chemistry II |
| title_sort | comprehensive medicinal chemistry ii global perspective |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015449784&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV022238800 |
| work_keys_str_mv | AT taylorjohnb comprehensivemedicinalchemistryii1 |